| Hans-Günter Meyer-Thompson | Hepatitiden
Effect of voluntary licences for hepatitis C medicines on access to treatment: a difference-in-differences analysis
Effect of voluntary licences for hepatitis C medicines on access to treatment: a difference-in-differences analysis
Simmons, Bryony et al.
The Lancet Global Health, Volume 7, Issue 9, e1189 - e1196
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(19)30266-9/fulltext